Cystic Fibrosis

  • Annick Clement
  • Harriet Corvol
  • Brigitte Fauroux
Part of the Molecular Pathology Library book series (MPLB, volume 1)


Cystic fibrosis (CF) is the most common lethal inherited disease of Caucasians. It is a disease of exocrine gland function involving many tissues and leading to a diverse range of pathologic and clinical problems. Although most patients have multiple organ involvement, pulmonary disease is the principal cause of both morbidity and mortality in more than 90% of patients surviving the neonatal period.1,2


Cystic Fibrosis Respir Crit Airway Surface Liquid Sweat Test CFTR Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ratjen F, Doring G. Cystic fibrosis. Lancet 2003;361:681–689.CrossRefPubMedGoogle Scholar
  2. 2.
    Robinson P. Cystic fibrosis. Thorax 2001;56:237–241.CrossRefPubMedGoogle Scholar
  3. 3.
    Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066–1073.CrossRefPubMedGoogle Scholar
  4. 4.
    Akabas MH. Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel. J Biol Chem 2000;275:3729–3732.CrossRefPubMedGoogle Scholar
  5. 5.
    McAuley DF, Elborn JS. Cystic fibrosis: basic science. Paediatr Respir Rev 2000;1:93–100.CrossRefPubMedGoogle Scholar
  6. 6.
    Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005;352:1992–2001.CrossRefPubMedGoogle Scholar
  7. 7.
    Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79:S23–S45.PubMedGoogle Scholar
  8. 8.
    Gao L, Kim KJ, Yankaskas JR, Forman HJ. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol 1999;277:L113–L118.PubMedGoogle Scholar
  9. 9.
    Gao L, Broughman JR, Iwamoto T, Tomich JM, et al. Synthetic chloride channel restores glutathione secretion in cystic fibrosis airway epithelia. Am J Physiol Lung Cell Mol Physiol 2001;281:L24–L30.PubMedGoogle Scholar
  10. 10.
    Pilewski J, Frizzell R. Role of CFTR in airway disease. Physiol Rev 1999;79:S215–S255.PubMedGoogle Scholar
  11. 11.
    Tarran R, Grubb BR, Parsons D, et al. The CF salt controversy: in vivo observations and therapeutic approaches. 2001;8:149–158.Google Scholar
  12. 12.
    Tarran R, Boucher RC. Thin-film measurements of airway surface liquid volume/composition and mucus transport rates in vitro. Methods Mol Med 2002;70:479–492.PubMedGoogle Scholar
  13. 13.
    Jayaraman S, Joo NS, Reitz B, et al. Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc Natl Acad Sci 2001;98:8119–8123.CrossRefPubMedGoogle Scholar
  14. 14.
    Jayaraman S, Song Y, Vetrivel L, et al. Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH. 2001;107:317–324.Google Scholar
  15. 15.
    Aldallal N, McNaughton EE, Manzel LJ, et al. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am J Respir Crit Care Med 2002;166:1248–1256.CrossRefPubMedGoogle Scholar
  16. 16.
    Stecenko A, King G, Torii K, et al. Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 2001;25:145–155.CrossRefPubMedGoogle Scholar
  17. 17.
    Velsor LW, van Heeckeren A, Day BJ. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. 2001;281:L31–L38.Google Scholar
  18. 18.
    Accurso FJ. Early pulmonary disease in cystic fibrosis. Curr Opin Pulm Med 1997;3:400–403.CrossRefPubMedGoogle Scholar
  19. 19.
    Armstrong DS, Grimwood K, Carlin JB, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:1197–1204.PubMedGoogle Scholar
  20. 20.
    Khan TZ, Wagener JS, Bost T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit care Med 1995;151:1075–1082.PubMedGoogle Scholar
  21. 21.
    Corvol H, Fitting C, Chadelat K, et al. Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2003;284:L997–L1003.PubMedGoogle Scholar
  22. 22.
    Osika E, Cavaillon JM, Chadelat K, et al. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 1999;14:339–346.CrossRefPubMedGoogle Scholar
  23. 23.
    Tirouvanziam R, Khazaal I, Peault B. Primary inflammation in human cystic fibrosis small airways. 2002;283:L445–L451.Google Scholar
  24. 24.
    Scheid P, Kempster L, Griesenbach U, et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 2001;17:27–35.CrossRefPubMedGoogle Scholar
  25. 25.
    Armstrong DS, Hook SM, Jamsen KM, et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 2005;40:500–510.CrossRefPubMedGoogle Scholar
  26. 26.
    Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 1996;22:387–395.CrossRefPubMedGoogle Scholar
  27. 27.
    Kerem E, Kerem B. The relationship between genotype and phenotype in cystic fibrosis. Curr Opin Pulm Med 1995;1:450–456.CrossRefPubMedGoogle Scholar
  28. 28.
    Drumm ML. Modifier genes and variation in cystic fibrosis. Respir Res 2001;2:125–128.CrossRefPubMedGoogle Scholar
  29. 29.
    Drumm ML, Konstan MW, Schluchter MD, et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005;353:1443–1453.CrossRefPubMedGoogle Scholar
  30. 30.
    Flamant C, Henrion-Caude A, Boelle P, et al. Glutathione-S-transferase, M1, M3, P1, and T1 polymorphisms and severity of lung disease in children with cystic fibrosis. Pharmacogenetics 2004;14:295–301.CrossRefPubMedGoogle Scholar
  31. 31.
    Hull J, Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 1998;53:1018–1021.CrossRefPubMedGoogle Scholar
  32. 32.
    Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 2002;111:88–95.CrossRefPubMedGoogle Scholar
  33. 33.
    Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000;67:117–133.CrossRefPubMedGoogle Scholar
  34. 34.
    Davis PB, Drumm M, Konstan MW. Cystic fibrosis. 1996;154:1229–1256.Google Scholar
  35. 35.
    Bush A, Accurso F, Macnee W, et al. Cystic fibrosis, pediatrics, control of breathing, pulmonary physiology and anatomy, and surfactant biology in AJRCCM in 2004. Am J Respir Crit Care Med 2005;171:545–553.CrossRefPubMedGoogle Scholar
  36. 36.
    Stern S. The diagnosis of cystic fibrosis. N Engl J Med 1997;336:487–491.CrossRefPubMedGoogle Scholar
  37. 37.
    De Boeck K, Wilschanski M, Castellani C, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006;61:627–635.CrossRefPubMedGoogle Scholar
  38. 38.
    De Braekeleer M, Allard C, Leblanc JP, et al. Genotype-phenotype correlation in cystic fibrosis patients compound heterozygous for the A455E mutation. Hum Genet 1997;101:208–211.CrossRefPubMedGoogle Scholar
  39. 39.
    Marshall B. Pulmonary exacerbations in cystic fibrosis. Am J Respir Crit Care Med 2004;169:781–782.CrossRefPubMedGoogle Scholar
  40. 40.
    Dezateux C. Screening newborn infants for cystic fibrosis. J Med Screen 2001;8:57–58.CrossRefPubMedGoogle Scholar
  41. 41.
    Doull IJ, Ryley HC, Weller P, Goodchild MC. Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatr Pulmonol 2001;31:363–366.CrossRefPubMedGoogle Scholar
  42. 42.
    Larsson A. Neonatal screening for metabolic, endocrine, infectious, and genetic disorders. Current and future directions. Clin Perinatol 2001;28:449–461.CrossRefPubMedGoogle Scholar
  43. 43.
    McCormick J, Green MW, Mehta G, et al. Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet 2002;10:583–590.CrossRefPubMedGoogle Scholar
  44. 44.
    Young SS, Kharrazi M, Pearl M, Cunningham G. Cystic fibrosis screening in newborns: results from existing programs. Curr Opin Pulm Med 2001;7:427–433.CrossRefPubMedGoogle Scholar
  45. 45.
    Baumer JH. Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. Arch Dis Child 2003;88:1126–1127.CrossRefPubMedGoogle Scholar
  46. 46.
    Wallace HL, Barker PM, Southern KW. Nasal airway ion transport and lung function in young people with cystic fibrosis. Am J Respir Crit Care Med 2003;168:594–600.CrossRefPubMedGoogle Scholar
  47. 47.
    Griesenbach U, Geddes DM, Alton EW. Gene therapy progress and prospects: cystic fibrosis. Gene Ther 2006;13:1061–1067.CrossRefPubMedGoogle Scholar
  48. 48.
    Verkman AS, Lukacs GL, Galietta LJ. CFTR chloride channel drug discovery—inhibitors as antidiarrheals and activators for therapy of cystic fibrosis. Curr Pharm Des 2006;12:2235–2247.CrossRefPubMedGoogle Scholar
  49. 49.
    Jobin C, Bradhman CA, Russo Maria P, et al. Curcumin blocks cytokine-mediated NF-kB Activation and proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. J Immunol 1999;163:3474–3483.PubMedGoogle Scholar
  50. 50.
    Havermans T, De Boeck K. Cystic fibrosis: a balancing act? J Cyst Fibros 2007;6(2):161–162.CrossRefPubMedGoogle Scholar
  51. 51.
    Knowles MR, Durie PR. What is cystic fibrosis? N Engl J Med 2002;347:439–442.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Annick Clement
    • 1
  • Harriet Corvol
    • 2
  • Brigitte Fauroux
    • 2
  1. 1.Pediatric Pulmonology DepartmentHopital d’enfants Armand TrousseauParisFrance
  2. 2.Department of Pediatric PulmonologyHopital d’enfants Armand TrousseauParisFrance

Personalised recommendations